PLoS ONE (Jan 2014)

Cross talk with hematopoietic cells regulates the endothelial progenitor cell differentiation of CD34 positive cells.

  • Sang-Mo Kwon,
  • Jun-Hee Lee,
  • Sang-Hun Lee,
  • Seok-Yun Jung,
  • Da-Yeon Kim,
  • Song-Hwa Kang,
  • So-Young Yoo,
  • Jong-Kyu Hong,
  • Ji-Hye Park,
  • Jung-Hee Kim,
  • Sung-Wook Kim,
  • Yeon-Ju Kim,
  • Sun-Jin Lee,
  • Hwi-Gon Kim,
  • Takayuki Asahara

DOI
https://doi.org/10.1371/journal.pone.0106310
Journal volume & issue
Vol. 9, no. 8
p. e106310

Abstract

Read online

IntroductionDespite the crucial role of endothelial progenitor cells (EPCs) in vascular regeneration, the specific interactions between EPCs and hematopoietic cells remain unclear.MethodsIn EPC colony forming assays, we first demonstrated that the formation of EPC colonies was drastically increased in the coculture of CD34+ and CD34- cells, and determined the optimal concentrations of CD34+ cells and CD34- cells for spindle-shaped EPC differentiation.ResultsFunctionally, the coculture of CD34+ and CD34- cells resulted in a significant enhancement of adhesion, tube formation, and migration capacity compared with culture of CD34+ cells alone. Furthermore, blood flow recovery and capillary formation were remarkably increased by the coculture of CD34+ and CD34- cells in a murine hind-limb ischemia model. To elucidate further the role of hematopoietic cells in EPC differentiation, we isolated different populations of hematopoietic cells. T lymphocytes (CD3+) markedly accelerated the early EPC status of CD34+ cells, while macrophages (CD11b+) or megakaryocytes (CD41+) specifically promoted large EPC colonies.ConclusionOur results suggest that specific populations of hematopoietic cells play a role in the EPC differentiation of CD34+ cells, a finding that may aid in the development of a novel cell therapy strategy to overcome the quantitative and qualitative limitations of EPC therapy.